Cite
HARVARD Citation
Gallois, C. et al. (2021). Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial. Digestive and liver disease. 53 (10), pp. 1254-1259. [Online].